G6PD and neoplasm: Furthermore, the combination of oxaliplatin treatment and G6PD knockdown by PPMS polyplexes resulted in the more potent anti-tumor activity compared with oxaliplatin or G6PD knockdown alone, which was evident by the significant reduced PDX tumor growth and tumor weight (Figures 6e and f).